Skip to main content
Get in touch with us!
Ambit Welcomes Mike Blum as Executive Vice President

Ambit Welcomes Mike Blum as Executive Vice President

We are thrilled to announce that Mike Blum has joined Ambit as our new Executive Vice President (EVP). Mike is a seasoned leader, with 30 years of experience in rare disease and biologics, where he has consistently driven success through his strategic vision and deep ...
Read More

Top Blogs

Latest Blogs

3 min read
How Dynamic LeadGen Improves Upon Current Patient Identification Services
3 min read
Disease State Education 2.0
2 min read
Ambit Wins Global Genes’ RARE-X Xcelerate RARE Open Science Data Challenge
2 min read
Ambit Partners with Datavant to Drive Innovation in the Rare and Specialty Disease Markets
3 min read
Understanding the Symptom Differentiation Between Angelman Syndrome and SYNGAP1-Related DEEs
3 min read
Reflecting on One Year of Impact: Celebrating and Building on our Achievements
2 min read
Ambit Redefines Biopharma Solutions with Dynamic New Branding Approach
2 min read
Ambit Hires Jonathan Woodring as Chief Innovation Officer
2 min read
Ambit Inc. to Present Novel Projection Methodology for Rare Developmental and Epileptic Encephalopathies (DEEs) at the 2022 Child Neurology Society Annual Meeting
image